The targets of gene therapy for AD fall into four main categories: catabolism of amyloid precursor protein (APP) and removal of Aβ, neuroprotective genes, growth factors, and apolipoprotein E (ApoE) alleles. The gene discussed is APP; the disease is Alzheimer disease.